{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T05:14:01Z","timestamp":1773897241094,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T00:00:00Z","timestamp":1660867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["00023001"],"award-info":[{"award-number":["00023001"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tuberculosis (TBC) in solid organ transplant recipients represents a severe complication. The incidence among transplant recipients is higher than in the general population, and the diagnosis and treatment remain challenging. We present a case of active disseminated tuberculosis in a kidney transplant recipient treated with an anti-CD40 monoclonal antibody, who had been previously exposed to an active form of the disease, but latent tuberculosis (LTBI) was repeatedly ruled out prior to transplantation. To the best of our knowledge, no other case has been reported in a patient treated with the anti-CD40 monoclonal antibody.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 49-year-old patient, 1.5\u00a0years after primary kidney transplantation, presented with vocal cord problems, a dry irritating cough, and a sore throat. A detailed investigation, including a high-resolution chest CT scan, revealed the diagnosis of disseminated tuberculosis. The antituberculosis treatment consisting of rifampicin, isoniazid, pyrazinamide, and ethambutol was started immediately. The patient's condition became complicated by relapsing diarrhoea. The colonoscopy revealed a circular stenosis above Bauhin\u2019s valve. Microscopical findings showed active colitis and vaguely formed collections of epithelioid macrophages without fully developed caseous granulomas and were consistent with the clinical diagnosis of tuberculosis. The antituberculosis treatment was subsequently enhanced by moxifloxacin and led to a great improvement in the patient\u2019s condition.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In this case, false negativity of interferon-\u03b3 release assays and possibly higher risk for intracellular infections in patients on costimulatory signal blockers are discussed.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-022-02916-2","type":"journal-article","created":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:03:58Z","timestamp":1660896238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report"],"prefix":"10.1186","volume":"23","author":[{"given":"Kamila","family":"Bednarova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janka","family":"Slatinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Fabian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Wohl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Kopecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Viklicky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,19]]},"reference":[{"issue":"3","key":"2916_CR1","doi-asserted-by":"publisher","first-page":"213","DOI":"10.5500\/wjt.v7.i3.213","volume":"7","author":"M Anand","year":"2017","unstructured":"Anand M, Nayyar E, Concepcion B, Salani M, Schaefer H. Tuberculosis in kidney transplant recipients: A case series. World J Transplant. 2017;7(3):213\u201321.","journal-title":"World J Transplant"},{"issue":"4","key":"2916_CR2","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1183\/09031936.00000712","volume":"40","author":"D Bumbacea","year":"2012","unstructured":"Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40(4):990\u20131013.","journal-title":"Eur Respir J"},{"key":"2916_CR3","unstructured":"UZIS Health Statistics. Basic Overview of Tuberculosis Epidemiology in the Czech Republic in 2020. 2021. ISSN: 1210\u20138685, (0862\u20135670). Available online: https:\/\/www.uzis.cz\/res\/f\/008358\/tbc2020-en.pdf."},{"issue":"11","key":"2916_CR4","first-page":"e11661","volume":"12","author":"S Sasi","year":"2020","unstructured":"Sasi S, Varghese MK, Nair AP, Hashim S, Al MM. Tuberculosis in an allogeneic transplant kidney: a rare case report and review of literature. Cureus. 2020;12(11):e11661.","journal-title":"Cureus"},{"issue":"1","key":"2916_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1164\/rccm.201006-0974OC","volume":"183","author":"R Diel","year":"2011","unstructured":"Diel R, Loddenkemper R, Niemann S, Meywald-Walter K, Nienhaus A. Negative and positive predictive value of a whole-blood interferon-\u03b3 release assay for developing active tuberculosis: an update. Am J Respir Crit Care Med. 2011;183(1):88\u201395.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2916_CR6","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ejim.2007.03.020","volume":"19","author":"M Hornum","year":"2008","unstructured":"Hornum M, Mortensen KL, Kamper AL, Andersen AB. Limitations of the QuantiFERON-TB Gold test in detecting Mycobacterium tuberculosis infection in immunocompromised patients. Eur J Intern Med. 2008;19(2):137\u20139.","journal-title":"Eur J Intern Med"},{"issue":"4","key":"2916_CR7","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/cid\/ciz851","volume":"71","author":"CC Shu","year":"2020","unstructured":"Shu CC, Tsai MK, Lin SW, Wang JY, Yu CJ, Lee CY. Latent tuberculosis infection increases in kidney transplantation recipients compared with transplantation candidates: a neglected perspective in tuberculosis control. Clin Infect Dis. 2020;71(4):914\u201323.","journal-title":"Clin Infect Dis"},{"key":"2916_CR8","unstructured":"National Institute for Health and Care Excellence (NICE). Tuberculosis. NICE guideline [NG33] [12 September 2019:[Available from: www.nice.org.uk\/guidance\/ng33."},{"key":"2916_CR9","unstructured":"TB Controllers. A GUIDE FOR HEALTH CARE PROVIDERS AND PUBLIC HEALTH PROGRAMS - Testing and treatment of latent tuberculosis infection in the United States: Clinical Recommendations.http:\/\/www.tbcontrollers.org\/docs\/resources\/tb-infection\/LTBI_Clinical_Recommendations_Version_002052021.pdf (Accessed on March 22, 2022)."},{"key":"2916_CR10","unstructured":"Polcova V, Vasakova M, Valentova-Bartakova L. Tuberkul\u00f3za (TB) a latentn\u00ed tuberkul\u00f3zn\u00ed infekce u pacient\u016f p\u0159ed a po transplantaci solidn\u00edch org\u00e1n\u016f \u010di hematopoetick\u00fdch kmenov\u00fdch bun\u011bk (Doporu\u010den\u00fd postup diagnostiky a l\u00e9\u010dby). http:\/www.pneumologie.cz\/guidelines2016. p. Kap. 4.5."},{"key":"2916_CR11","unstructured":"World Health Organization.\u00a0(2018).\u00a0Latent tuberculosis infection: updated and consolidated guidelines for programmatic management; Licence: CC BY-NC-SA 3.0 IGO;\u00a0World Health Organization: Geneva, Switzerland, 2018. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/260233. (accessed on 20 February 2022)"},{"key":"2916_CR12","unstructured":"World Health Organization. WHO Consolidated guidelines on tuberculosis. In Module 1: Prevention\u2014Tuberculosis preventive treatment; Licence: CC BY-NC-SA 3.0 IGO; World Health Organization: Geneva, Switzerland, 2020. Available online: htps:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/331170\/9789240001503-eng.pdf?sequence=1&isAllowed=y (accessed on 20 February 2022)."},{"issue":"2","key":"2916_CR13","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/ajt.15661","volume":"20","author":"P Espi\u00e9","year":"2020","unstructured":"Espi\u00e9 P, He Y, Koo P, Sickert D, Dupuy C, Chokot\u00e9 E, et al. First-in-human clinical trial to assess pharmacokinetics, pharmacodynamics, safety, and tolerability of iscalimab, an anti-CD40 monoclonal antibody. Am J Transplant. 2020;20(2):463\u201373.","journal-title":"Am J Transplant"},{"issue":"6","key":"2916_CR14","doi-asserted-by":"publisher","first-page":"e1002676","DOI":"10.1371\/journal.ppat.1002676","volume":"8","author":"N Khan","year":"2012","unstructured":"Khan N, Gowthaman U, Pahari S, Agrewala JN. Manipulation of costimulatory molecules by intracellular pathogens veni, vidi, vici!! PLoS Pathog. 2012;8(6):e1002676.","journal-title":"PLoS Pathog"},{"issue":"10","key":"2916_CR15","doi-asserted-by":"publisher","first-page":"e1179","DOI":"10.1002\/cti2.1179","volume":"9","author":"P Chauhan","year":"2020","unstructured":"Chauhan P, Dandapat J, Sarkar A, Saha B. March of Mycobacterium: miRNAs intercept host cell CD40 signalling. Clin Transl Immunology. 2020;9(10):e1179.","journal-title":"Clin Transl Immunology"},{"issue":"8","key":"2916_CR16","doi-asserted-by":"publisher","first-page":"e1006530","DOI":"10.1371\/journal.ppat.1006530","volume":"13","author":"JK Sia","year":"2017","unstructured":"Sia JK, Bizzell E, Madan-Lala R, Rengarajan J. Engaging the CD40-CD40L pathway augments T-helper cell responses and improves control of Mycobacterium tuberculosis infection. PLoS Pathog. 2017;13(8):e1006530.","journal-title":"PLoS Pathog"},{"issue":"3","key":"2916_CR17","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1111\/j.1600-6143.2011.03914.x","volume":"12","author":"JO Pestana","year":"2012","unstructured":"Pestana JO, Grinyo JM, Vanrenterghem Y, Becker T, Campistol JM, Florman S, et al. Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant. 2012;12(3):630\u20139.","journal-title":"Am J Transplant"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-022-02916-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-022-02916-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T08:06:00Z","timestamp":1660896360000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-022-02916-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,19]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2916"],"URL":"https:\/\/doi.org\/10.1186\/s12882-022-02916-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,19]]},"assertion":[{"value":"17 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. All patient data was anonymized. A copy of the written consent is available for review. This manuscript does not require other. The research was conducted ethically in accordance with the World Health Association Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"290"}}